Cargando…
Post‐treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer
To date, there has been no evidence regarding the association between urinary sarcosine content and prostate cancer survival. Our main objective was to investigate whether levels of post‐treatment urinary sarcosine are associated with relapse. The inclusion criteria were (in accordance with EAU 2017...
Autores principales: | Gumulec, Jaromir, Raudenska, Martina, Pacik, Dalibor, Plevova, Mariana, Sorokac‐Kubolkova, Alena, Lackova, Zuzana, Cernei, Natalia, Strmiska, Vladislav, Zitka, Ondrej, Heger, Zbynek, Adam, Vojtech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246947/ https://www.ncbi.nlm.nih.gov/pubmed/30209891 http://dx.doi.org/10.1002/cam4.1767 |
Ejemplares similares
-
Identification of Sarcosine as a Target Molecule for the Canine Olfactory Detection of Prostate Carcinoma
por: Pacik, Dalibor, et al.
Publicado: (2018) -
Sarcosine as a Potential Prostate Cancer Biomarker—A Review
por: Cernei, Natalia, et al.
Publicado: (2013) -
Sarcosine is a prostate epigenetic modifier that elicits aberrant methylation patterns through the SAMe‐Dnmts axis
por: Strmiska, Vladislav, et al.
Publicado: (2019) -
Paramagnetic Nanoparticles as a Platform for FRET-Based Sarcosine Picomolar Detection
por: Heger, Zbynek, et al.
Publicado: (2015) -
Influence of Long-Distance Bicycle Riding on Serum/Urinary Biomarkers of Prostate Cancer
por: Heger, Zbynek, et al.
Publicado: (2016)